However, when BC-treated Ztm male mice were compared with the WT reference male mice, all evaluated RNA transcripts (Erbb2, Plec, Ctnnd1, Afdn, and Cldn2) had a q-value of 1, indicating no significant differences in their expression levels between Ztm mice post BC treatment. The gene discussed is CLDN2; the disease is breast cancer.